Sunshine Biopharma (SBFM) Other financing activities (2018 - 2025)

Sunshine Biopharma's Other financing activities history runs 6 years deep, the most recent figure standing at $724500.0 for Q4 2025.

• Quarterly Other financing activities fell 55.23% year-over-year to $724500.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $2.9 million (down 24.54% YoY) and the FY2025 annual result came in at $2.9 million, down 17.96% from the prior year.
• Other financing activities was $724500.0 for Q4 2025 at Sunshine Biopharma, down from $1.8 million in the prior quarter.
• Across five years, Other financing activities topped out at $13.2 million in Q4 2022 and bottomed at $1156.0 in Q2 2023.
• A 4-year average of $3.7 million and a median of $1.6 million in 2024 frame the typical range for Other financing activities.
• Annual changes were most pronounced in 2024 — Other financing activities tumbled 87.74% — and 2025, when it jumped 689.55%.
• Sunshine Biopharma's Other financing activities stood at $13.2 million in 2022, then declined by 0.01% to $13.2 million in 2023, then tumbled by 87.74% to $1.6 million in 2024, then plunged by 55.23% to $724500.0 in 2025.
• Business Quant data shows SBFM's Other financing activities at $724500.0 in Q4 2025, $1.8 million in Q2 2025, and $355297.0 in Q1 2025.